Pfizer and BioNTech said a late-stage trial of their experimental mRNA vaccine to protect against influenza and COVID-19 ...
6don MSN
Lofty expectations for continuing sales of vaccines and antivirals have fallen short, sending Pfizer's stock price tumbling ...
Pfizer said on Monday its respiratory syncytial virus (RSV) vaccine Abrysvo generated a strong immune response in a ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Pfizer and BioNTech may have a strong pedigree in the mRNA vaccine game, but, when it comes to flu, they’ve run up against ...
A combination Covid-flu vaccination developed by Pfizer Inc. and BioNTech SE missed on one of its goals in a final-stage ...
Germany's BioNTech and US pharma giant Pfizer said Friday they had suffered a setback in a late-stage trial of their combined ...
Pfizer and BioNTech said Friday that a Phase 3 trial of their COVID-19-and-influenza combination vaccine candidate met one of ...
Pfizer and BioNTech’s Covid-19 and flu vaccine failed to meet a key goal in a late-stage trial, jeopardising a highly ...
Opinions expressed by Forbes Contributors are their own. We provide aggregated data on dividend stocks. In trading on Friday, ...
In a Phase 3 trial, Pfizer and BioNTech’s combination vaccine candidate against influenza and COVID-19 met one of its two primary immunogenicity ...
The Motley Fool on MSN2d
Why Pfizer Stock Slumped on FridayInvestors were cautiously pessimistic about the latest news coming out of the company's lab. Before market open, Pfizer and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results